WESSON BRUCE F 4

4 · ACURA PHARMACEUTICALS, INC · Filed Jan 8, 2019

Form 4

Period: 2019-01-02

Director

Transactions

Exercise/Conversion
Restricted Stock Units (2017 Plan)
2019-01-02−66,666→ 0 total
→ Common Stock (66,666 underlying)
Exercise/Conversion
Common Stock
2019-01-02+66,666→ 520,593 total
Award
Restricted Stock Units (2017 Plan)
2019-01-02+83,333→ 83,333 total
→ Common Stock (83,333 underlying)

Footnotes (7)

[F1]Represents exchange of restricted stock units.
[F2]Par value of $.01 per share must be paid by Reporting Person upon exchange of Restricted Stock Units for stock
[F3]Does not include Restricted Stock Units.
[F4]1 - for - 1
[F5]25% of Restricted Stock Units vested on March 31, 2018, 25% vested on June 30, 2018; 25% vested on September 30, 2018 and 25% vested on December 31, 2018. Restricted Stock Units are being exchanged on a one for one basis for common stock, in each case upon payment of par value.
[F6]N/A
[F7]25% of Restricted Stock Units vest on the last day of each of March, June, September and December 2019, subject to immediate vesting in the event of a change of control and certain other events. Reporting Person may elect to exchange up to 40% of Restricted Stock Units for cash and the remaining Restricted Stock Units will be exchanged on a one for one basis for common stock, in each case upon payment of, or deduction of par value. Distributions in respect of vested Restricted Stock Units will be made on the first business day of January 2020, or earlier upon a change of control.

Documents

1 file